Abstract
Proper functioning of the brain is dependent on integrity of the cerebral vasculature. During ageing, a number of factors including aortic or arterial stiffness, autonomic dysregulation, neurovascular uncoupling and blood-brain barrier (BBB) damage will define the dynamics of brain blood flow and local perfusion. The nature and extent of ageing-related cerebrovascular changes, the degree of involvement of the heart and extracranial vessels and the consequent location of tissue pathology may vary considerably. Atheromatous disease retarding flow is a common vascular insult, which increases exponentially with increasing age. Arteriolosclerosis characterized as a prominent feature of small vessel disease is one of the first changes to occur during the natural history of cerebrovascular pathology. At the capillary level, the cerebral endothelium, which forms the BBB undergoes changes including reduced cytoplasm, fewer mitochondria, loss of tight junctions and thickened basement membranes with collagenosis. Astrocyte end-feet protecting the BBB retract as part of the clasmatodendrotic response whereas pericyte coverage is altered. The consequences of these microvascular changes are lacunar infarcts, cortical and subcortical microinfarcts, microbleeds and diffuse white matter disease, which involves myelin loss and axonal abnormalities. The deeper structures are particularly vulnerable because of the relatively reduced density of the microvascular network formed by perforating and penetrating end arteries. Ultimately, the integrity of both the neurovascular and gliovascular units is compromised such that there is an overall synergistic effect reflecting on ageing associated cerebral perfusion and permeability. More than one protagonist appears to be involved in ageing-related cognitive dysfunction characteristically associated with the neurocognitive disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akinyemi RO, Allan L, Oakley A, Kalaria R (2017) Hippocampal neurodegenerative pathology in post-stroke dementia compared to other dementias and ageing controls. Front Neurosci 11:717. https://doi.org/10.3389/fnins.2017.00717
Allan LM, Rowan EN, Firbank MJ, Thomas AJ, Parry SW, Polvikoski TM, O’Brien JT, Kalaria RN (2012) Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain J Neurol 134(Pt 12):3716–3727. https://doi.org/10.1093/brain/awr273
Ambarki K, Wahlin A, Zarrinkoob L, Wirestam R, Petr J, Malm J, Eklund A (2015) Accuracy of parenchymal cerebral blood flow measurements using pseudocontinuous arterial spin-labeling in healthy volunteers. AJNR Am J Neuroradiol 36(10):1816–1821. https://doi.org/10.3174/ajnr.A4367
Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA (2011a) Microinfarct pathology, dementia, and cognitive systems. Stroke 42(3):722–727. https://doi.org/10.1161/STROKEAHA.110.595082
Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA (2011b) Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 69(2):320–327. https://doi.org/10.1002/ana.22112
Association AP (2013) Diagnostic and statistical manual of mental disorders, vol 5. APA, USA
Attems J, Jellinger K, Thal DR, Van Nostrand W (2011) Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 37(1):75–93. https://doi.org/10.1111/j.1365-2990.2010.01137.x
Bailey EL, Smith C, Sudlow CL, Wardlaw JM (2012) Pathology of lacunar ischemic stroke in humans – a systematic review. Brain Pathol 22(5):583–591. https://doi.org/10.1111/j.1750-3639.2012.00575.x
Ballard C, McKeith I, O'Brien J, Kalaria R, Jaros E, Ince P, Perry R (2000) Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. Dement Geriatr Cogn Disord 11(2):59–65
Bejot Y, Aboa-Eboule C, Durier J, Rouaud O, Jacquin A, Ponavoy E, Richard D, Moreau T, Giroud M (2011) Prevalence of early dementia after first-ever stroke: a 24-year population-based study. Stroke; J Cereb Circ 42(3):607–612. https://doi.org/10.1161/STROKEAHA.110.595553
Brown WR, Thore CR (2011) Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 37(1):56–74. https://doi.org/10.1111/j.1365-2990.2010.01139.x
Brown WR, Moody DM, Challa VR, Thore CR, Anstrom JA (2002a) Apoptosis in leukoaraiosis lesions. J Neurol Sci 203–204:169–171
Brown WR, Moody DM, Challa VR, Thore CR, Anstrom JA (2002b) Venous collagenosis and arteriolar tortuosity in leukoaraiosis. J Neurol Sci 203–204:159–163
Burke MJC, Nelson L, Slade JY, Oakley AE, Khundakar AA, Kalaria RN (2014) Morphometry of the hippocampal microvasculature in post-stroke and age- related dementias. Neuropathol Appl Neurobiol 40(3):284–295. https://doi.org/10.1111/nan.12085
Cadavid D, Mena H, Koeller K, Frommelt RA (2000) Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 59(9):768–773
Caplan LR (2008) Uncommon causes of stroke, 2nd edn. Cambridge University Press, Cambridge
Charidimou A, Gang Q, Werring DJ (2012) Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 83(2):124–137. https://doi.org/10.1136/jnnp-2011-301308
Chen XY, Wong KS, Lam WW, Zhao HL, Ng HK (2008) Middle cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis 25(1–2):74–80. https://doi.org/10.1159/000111525
Chen A, Akinyemi RO, Hase Y, Firbank MJ, Ndung’u MN, Foster V, Craggs LJ, Washida K, Okamoto Y, Thomas AJ, Polvikoski TM, Allan LM, Oakley AE, O’Brien JT, Horsburgh K, Ihara M, Kalaria RN (2016) Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia. Brain 139(Pt 1):242–258. https://doi.org/10.1093/brain/awv328
Cohen DL, Hedera P, Premkumar DR, Friedland RP, Kalaria RN (1997) Amyloid-beta protein angiopathies masquerading as Alzheimer’s disease? Ann N Y Acad Sci 826:390–395
Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, Kalaria RN (2012) Staging and natural history of cerebrovascular pathology in dementia. Neurology 78(14):1043–1050. https://doi.org/10.1212/WNL.0b013e31824e8e7f
Dorheim MA, Tracey WR, Pollock JS, Grammas P (1994) Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer’s disease. Biochem Biophys Res Commun 205(1):659–665. https://doi.org/10.1006/bbrc.1994.2716
Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, Part XV. Neurology 46(6):1592–1596
Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, Hartung HP (1999) Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 20(4):637–642
Ferro JM, Massaro AR, Mas JL (2010) Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol 9(11):1085–1096. https://doi.org/10.1016/S1474-4422(10)70251-9
Filosto M, Tomelleri G, Tonin P, Scarpelli M, Vattemi G, Rizzuto N, Padovani A, Simonati A (2007) Neuropathology of mitochondrial diseases. Biosci Rep 27(1–3):23–30. https://doi.org/10.1007/s10540-007-9034-3
Fisher CM (1982) Lacunar strokes and infarcts: a review. Neurology 32(8):871–876
Giwa MO, Williams J, Elderfield K, Jiwa NS, Bridges LR, Kalaria RN, Markus HS, Esiri MM, Hainsworth AH (2012) Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology 78(3):167–174. https://doi.org/10.1212/WNL.0b013e3182407968
Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S, American Heart Association Stroke Council CoE, Prevention CoCNCoCR, Intervention, Council on Cardiovascular S, Anesthesia (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 42(9):2672–2713. https://doi.org/10.1161/STR.0b013e3182299496
Grinberg LT, Thal DR (2010) Vascular pathology in the aged human brain. Acta Neuropathol 119(3):277–290. https://doi.org/10.1007/s00401-010-0652-7
Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Dichgans M, Marler JR, Leblanc GG (2006a) National institute of neurological disorders and stroke-canadian stroke network vascular cognitive impairment harmonization standards. Stroke 37(9):2220–2241
Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG (2006b) National institute of neurological disorders and stroke-canadian stroke network vascular cognitive impairment harmonization standards. Stroke 37(9):2220–2241. https://doi.org/10.1161/01.STR.0000237236.88823.47
Haglund M, Passant U, Sjobeck M, Ghebremedhin E, Englund E (2006) Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry 21(7):681–687. https://doi.org/10.1002/gps.1550
Ho KL, Garcia JH (2000) Neuropathology of the small blood vessels in selected disease of the cerebral white matter. In: Pantoni L, Inzitari D, Wallin A (eds) The matter of white matter. Current issues in neurodegenerative diseases. Academic Pharmaceutical Productions, Utrecht, pp 247–273
Horie R (1977) Studies on stroke in relation to cerebrovascular atherogenesis in stroke-prone spontaneously hypertensive rats (SHRSP). Nihon Geka Hokan 46(3):191–213
Hunziker O, Abdel’Al S, Schulz U (1979) The aging human cerebral cortex: a stereological characterization of changes in the capillary net. J Gerontol 34(3):345–350
Ince PG, Minett T, Forster G, Brayne C, Wharton SB, Medical Research Council Cognitive F, Ageing Neuropathology S (2017) Microinfarcts in an older population-representative brain donor cohort (MRC CFAS): prevalence, relation to dementia and mobility, and implications for the evaluation of cerebral small vessel disease. Neuropathol Appl Neurobiol 43(5):409–418. https://doi.org/10.1111/nan.12363
Jackson C, Sudlow C (2005) Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain 128(Pt 11):2507–2517. https://doi.org/10.1093/brain/awh636
Janaway BM, Simpson JE, Hoggard N, Highley JR, Forster G, Drew D, Gebril OH, Matthews FE, Brayne C, Wharton SB, Ince PG, Function MRCC, Ageing Neuropathology S (2014) Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds. Neuropathol Appl Neurobiol 40(3):258–269. https://doi.org/10.1111/nan.12062
Jashari F, Ibrahimi P, Nicoll R, Bajraktari G, Wester P, Henein MY (2013) Coronary and carotid atherosclerosis: similarities and differences. Atherosclerosis 227(2):193–200. https://doi.org/10.1016/j.atherosclerosis.2012.11.008
Johnson PC, Brendel K, Meezan E (1982) Thickened cerebral cortical capillary basement membranes in diabetics. Arch Pathol Lab Med 106(5):214–217
Kalaria RN (1992) The blood-brain-barrier and cerebral microcirculation in Alzheimer-disease. Cerebrovas Brain Met 4(3):226–260
Kalaria RN (1996) Cerebral vessels in ageing and Alzheimer’s disease. Pharmacol Ther 72(3):193–214
Kalaria RN (2012) Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans. Stroke 43(9):2526–2534. https://doi.org/10.1161/STROKEAHA.112.655803
Kalaria RN (2016) Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease. Acta Neuropathol 131(5):659–685. https://doi.org/10.1007/s00401-016-1571-z
Kalaria RN, Harik SI (1988) Adenosine receptors and the nucleoside transporter in human-brain vasculature. J Cerebr Blood F Met 8(1):32–39. https://doi.org/10.1038/Jcbfm.1988.5
Kalaria RN, Sromek SM, Grahovac I, Harik SI (1992) Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimers-disease. Brain Res 585(1–2):87–93. https://doi.org/10.1016/0006-8993(92)91193-I
Kalaria RN, Premkumar DR, Pax AB, Cohen DL, Lieberburg I (1996) Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer’s disease. Brain Res Mol Brain Res 35(1–2):58–68
Kalaria RN, Perry RH, O'Brien J, Jaros E (2012) Atheromatous disease in small intracerebral vessels, microinfarcts and dementia. Neuropathol Appl Neurobiol. https://doi.org/10.1111/j.1365-2990.2012.01264.x
Kalaria R, Ferrer I, Love S (2015a) Vascular disease, hypoxia and related conditions. In: Love S, Arie P, Ironside J, Budka H (eds) Greenfield’s neuropathology, vol 1, 9th edn. CRC Press, London, pp 59–209
Kalaria RN, Ferrer I, Love S (2015b) Vascular disease, hypoxia and related conditions. In: Love S, Perry A, Ironside J, Budka H (eds) Greenfield’s neuropathology, vol 1, 9th edn. CRC Press, London, pp 59–209
Kawai M, Kalaria RN, Harik SI, Perry G (1990) The relationship of amyloid plaques to cerebral capillaries in Alzheimers-disease. Am J Pathol 137(6):1435–1446
Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, Chan HW, Greenberg BD, Perry G (1993) Degeneration of vascular muscle-cells in cerebral amyloid angiopathy of Alzheimer-disease. Brain Res 623(1):142–146. https://doi.org/10.1016/0006-8993(93)90021-E
Kovari E, Herrmann FR, Gold G, Hof PR, Charidimou A (2017) Association of cortical microinfarcts and cerebral small vessel pathology in the ageing brain. Neuropathol Appl Neurobiol 43(6):505–513. https://doi.org/10.1111/nan.12366
Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson LM, Truelsen T, O’Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C, Global Burden of Diseases IRFS, Group GBDSE (2013) Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the global burden of disease study 2010. Lancet Glob Health 1(5):e259–e281. https://doi.org/10.1016/S2214-109X(13)70089-5
Lammie GA, Brannan F, Slattery J, Warlow C (1997) Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke 28(11):2222–2229
Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F (2005) Poststroke dementia. Lancet Neurol 4(11):752–759
Li L, Yiin GS, Geraghty OC, Schulz UG, Kuker W, Mehta Z, Rothwell PM, Oxford Vascular S (2015) Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol 14(9):903–913. https://doi.org/10.1016/S1474-4422(15)00132-5
Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473(7347):317–325. https://doi.org/10.1038/nature10146
Lin J, Wang D, Lan L, Fan Y (2017) Multiple factors involved in the pathogenesis of white matter lesions. Biomed Res Int 2017:9372050. https://doi.org/10.1155/2017/9372050
Love S, Chalmers K, Ince P, Esiri M, Attems J, Kalaria R, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG (2015) Erratum: development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis 4(2):49
Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, Garcia M, Aspelund T, Harris TB, Gudnason V, Launer LJ (2011) Arterial stiffness, pressure and flow pulsatility and brain structure and function: the age, gene/environment susceptibility – Reykjavik study. Brain 134(Pt 11):3398–3407. https://doi.org/10.1093/brain/awr253
Mok VC, Lam BY, Wong A, Ko H, Markus HS, Wong LK (2017) Early-onset and delayed-onset poststroke dementia – revisiting the mechanisms. Nat Rev Neurol 13(3):148–159. https://doi.org/10.1038/nrneurol.2017.16
Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M, Zlokovic BV (2015) Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85(2):296–302. https://doi.org/10.1016/j.neuron.2014.12.032
Mooradian AD (1988) Effect of aging on the blood-brain barrier. Neurobiol Aging 9(1):31–39
Nagata K, Yamazaki T, Takano D, Maeda T, Fujimaki Y, Nakase T, Sato Y (2016) Cerebral circulation in aging. Ageing Res Rev 30:49–60. https://doi.org/10.1016/j.arr.2016.06.001
O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST (2003) Vascular cognitive impairment. Lancet Neurol 2(2):89–98
Ogata J, Yutani C, Otsubo R, Yamanishi H, Naritomi H, Yamaguchi T, Minematsu K (2008) Heart and vessel pathology underlying brain infarction in 142 stroke patients. Ann Neurol 63(6):770–781
Okamoto Y, Yamamoto T, Kalaria RN, Senzaki H, Maki T, Hase Y, Kitamura A, Washida K, Yamada M, Ito H, Tomimoto H, Takahashi R, Ihara M (2012) Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol 123(3):381–394. https://doi.org/10.1007/s00401-011-0925-9
Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ (1995) Cerebral infarction in Alzheimer’s disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 52(7):702–708
Pendlebury ST, Rothwell PM (2009) Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 8(11):1006–1018. S1474-4422(09)70236-4 [pii]. https://doi.org/10.1016/S1474-4422(09)70236-4
Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ (2002) Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 58(11):1629–1634
Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M (1997) Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory study (SAM) cohort. Stroke; J Cereb Circ 28(4):785–792
Roher AE, Tyas SL, Maarouf CL, Daugs ID, Kokjohn TA, Emmerling MR, Garami Z, Belohlavek M, Sabbagh MN, Sue LI, Beach TG (2011) Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia. Alzheimers Dement 7(4):436–444. S1552-5260(10)02421-0 [pii]. https://doi.org/10.1016/j.jalz.2010.08.228
Sachdev P (1999) Vascular cognitive disorder. Int J Geriatr Psychiatry 14(5):402–403
Sachdev P, Kalaria R, O'Brien J, Skoog I, Alladi S, Black SE, Blacker D, Blazer DG, Chen C, Chui H, Ganguli M, Jellinger K, Jeste DV, Pasquier F, Paulsen J, Prins N, Rockwood K, Roman G, Scheltens P, Internationlal Society for Vascular B, Cognitive D (2014) Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord 28(3):206–218. https://doi.org/10.1097/WAD.0000000000000034
Skrobot OA, Attems J, Esiri M, Hortobagyi T, Ironside JW, Kalaria RN, King A, Lammie GA, Mann D, Neal J, Ben-Shlomo Y, Kehoe PG, Love S (2016) Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain 139(11):2957–2969. https://doi.org/10.1093/brain/aww214
Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, O’Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I, group V, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG (2017a) Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the vascular impairment of cognition classification consensus study. Alzheimers Dement. https://doi.org/10.1016/j.jalz.2017.09.007
Skrobot OA, O’Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I, group V, Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG (2017b) The vascular impairment of cognition classification consensus study. Alzheimers Dement 13(6):624–633. https://doi.org/10.1016/j.jalz.2016.10.007
Smallwood A, Oulhaj A, Joachim C, Christie S, Sloan C, Smith AD, Esiri M (2012) Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Neuropathol Appl Neurobiol 38(4):337–343. https://doi.org/10.1111/j.1365-2990.2011.01221.x
Stary HC (2000) Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol 20(5):1177–1178
Stewart PA, Magliocco M, Hayakawa K, Farrell CL, Del Maestro RF, Girvin J, Kaufmann JC, Vinters HV, Gilbert J (1987) A quantitative analysis of blood-brain barrier ultrastructure in the aging human. Microvasc Res 33(2):270–282
Sweeney MD, Ayyadurai S, Zlokovic BV (2016) Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci 19(6):771–783. https://doi.org/10.1038/nn.4288
Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133–150. https://doi.org/10.1038/nrneurol.2017.188
Tanskanen M, Kalaria RN, Notkola IL, Makela M, Polvikoski T, Myllykangas L, Sulkava R, Kalimo H, Paetau A, Scheltens P, Barkhof F, van Straaten E, Erkinjuntti T (2013) Relationships between white matter hyperintensities, cerebral amyloid angiopathy and dementia in a population-based sample of the oldest old. Curr Alzheimer Res 10(10):1090–1097
Tarumi T, Zhang R (2018) Cerebral blood flow in normal aging adults: cardiovascular determinants, clinical implications, and aerobic fitness. J Neurochem 144(5):595–608. https://doi.org/10.1111/jnc.14234
Toth P, Tarantini S, Csiszar A, Ungvari Z (2017) Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. Am J Phys Heart Circ Phys 312(1):H1–H20. https://doi.org/10.1152/ajpheart.00581.2016
Tuzcu EM, Kapadia SR, Tutar E, Ziada KM, Hobbs RE, McCarthy PM, Young JB, Nissen SE (2001) High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 103(22):2705–2710
Van der Flier WM, Cordonnier C (2012) Microbleeds in vascular dementia: clinical aspects. Exp Gerontol 47(11):853–857. https://doi.org/10.1016/j.exger.2012.07.007
Vermeer SE, Longstreth WT Jr, Koudstaal PJ (2007) Silent brain infarcts: a systematic review. Lancet Neurol 6(7):611–619. https://doi.org/10.1016/S1474-4422(07)70170-9
Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, Chui HC (2000) Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 59(11):931–945
Viswanathan A, Patel P, Rahman R, Nandigam RN, Kinnecom C, Bracoud L, Rosand J, Chabriat H, Greenberg SM, Smith EE (2008) Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke; J Cereb Circ 39(7):1988–1992. https://doi.org/10.1161/STROKEAHA.107.509091
Wardlaw JM (2010) Blood-brain barrier and cerebral small vessel disease. J Neurol Sci 299(1–2):66–71
Wardlaw JM, Smith C, Dichgans M (2013) Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 12(5):483–497. https://doi.org/10.1016/S1474-4422(13)70060-7
Werring DJ, Gregoire SM, Cipolotti L (2011) Cerebral microbleeds and vascular cognitive impairment. J Neurol Sci 299(1–2):131–135. S0022-510X(10)00401-6 [pii]. https://doi.org/10.1016/j.jns.2010.08.034
Westover MB, Bianchi MT, Yang C, Schneider JA, Greenberg SM (2013) Estimating cerebral microinfarct burden from autopsy samples. Neurology 80(15):1365–1369. https://doi.org/10.1212/WNL.0b013e31828c2f52
Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S, Kong P, Nelson AR, Sullivan JS, Zhao Z, Meiselman HJ, Wendy RB, Soto J, Abel ED, Makshanoff J, Zuniga E, De Vivo DC, Zlokovic BV (2015) GLUT1 reductions exacerbate Alzheimer’s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 18(4):521–530. https://doi.org/10.1038/nn.3966
Zhang N, Gordon ML, Goldberg TE (2017) Cerebral blood flow measured by arterial spin labeling MRI at resting state in normal aging and Alzheimer’s disease. Neurosci Biobehav Rev 72:168–175. https://doi.org/10.1016/j.neubiorev.2016.11.023
Acknowledgments
We thank Yumi Yamamoto, Arthur Oakley and Janet Slade, previous members of the Neurovascular Research Group for providing continued technical support.
Funding Sources
Our work has been supported by the RCUK Newcastle Centre for Brain Ageing and Vitality, Medical Research Council (UK), Alzheimer’s Research UK, the Dunhill Medical Trust, UK and the Newcastle National Institute for Health Research Biomedical Research Centre in Ageing and Age Related Diseases, Newcastle upon Tyne Hospitals National Health Service Foundation Trust.
Competing Interests
We declare no competing interests.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kalaria, R.N., Hase, Y. (2019). Neurovascular Ageing and Age-Related Diseases. In: Harris, J., Korolchuk, V. (eds) Biochemistry and Cell Biology of Ageing: Part II Clinical Science. Subcellular Biochemistry, vol 91. Springer, Singapore. https://doi.org/10.1007/978-981-13-3681-2_17
Download citation
DOI: https://doi.org/10.1007/978-981-13-3681-2_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3680-5
Online ISBN: 978-981-13-3681-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)